Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Over the 40-year period during which bisphosphonates have been used in clinical practice, the mechanism of action for both simple and nitrogen-containing compounds has become clear, although sources variation in individual response still requires further investigation. The additional roles of bisphosphonates beyond osteoclastic inhibition also deserve further study. The targeting of bisphosphonates to bone means that few significant adverse consequences have been identified for the vast majority of those treated. © 2014 Elsevier Inc. All rights reserved.

Original publication

DOI

10.1016/B978-0-12-397165-4.00053-8

Type

Journal article

Publication Date

01/09/2013

Pages

495 - 500